Reperfusion Within 6 Hours Outperforms Recanalization in Predicting Penumbra Salvage, Lesion Growth, Final Infarct, and Clinical Outcome

Stroke

Volumn 46, Issue 6, 2015, Pages 1582-1589

  Cho, Tae Hee ^a   Nighoghossian, Norbert ^a   Mikkelsen, Irene Klærke ^b   Derex, Laurent ^a   Hermier, Marc ^a   Pedraza, Salvador ^c   Fiehler, Jens ^d   Østergaard, Leif ^b   Berthezène, Yves ^a   Baron, Jean Claude ^e,f  

^a UNIVERSITÉ LYON 1   (France)

^b AARHUS UNIVERSITY   (Denmark)

^c HOSPITAL JOSEP TRUETA   (Spain)

^d UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^e UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^f INSERM   (France)

Author keywords

magnetic resonance imaging; reperfusion

Indexed keywords

ALTEPLASE;

AGED; ARTICLE; BRAIN INFARCTION; BRAIN ISCHEMIA; DATA BASE; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; LOGISTIC REGRESSION ANALYSIS; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RECANALIZATION; RELIABILITY; REPERFUSION; BIOLOGICAL MODEL; BRAIN ANGIOGRAPHY; CLINICAL TRIAL; COMPARATIVE STUDY; FACTUAL DATABASE; MIDDLE AGED; MULTICENTER STUDY; NO-REFLOW PHENOMENON; PROSPECTIVE STUDY; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

AGED; BRAIN INFARCTION; CEREBRAL ANGIOGRAPHY; DATABASES, FACTUAL; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NO-REFLOW PHENOMENON; PROSPECTIVE STUDIES; REPERFUSION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84938545996     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.114.007964     Document Type: Article

References (35)

1. Mazighi M, Chaudhry SA, Ribo M, Khatri P, Skoloudik D, Mokin M, et al. Impact of onset-to-reperfusion time on stroke mortality: a collaborative pooled analysis. Circulation. 2013;127:1980-1985. doi: 10.1161/CIRCULATIONAHA.112.000311.
2. Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al; Stroke Thrombolysis Trialists' Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet. 2014;384:1929-1935. doi:10.1016/S0140-6736(14)60584-5.
3. Parsons M, Spratt N, Bivard A, Campbell B, Chung K, Miteff F, et al. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. N Engl J Med. 2012;366:1099-1107. doi: 10.1056/NEJMoa1109842.
4. Ames A III, Wright RL, Kowada M, Thurston JM, Majno G. Cerebral ischemia. II. The no-reflow phenomenon. Am J Pathol. 1968;52:437-453.
5. Alexandrov AV, Grotta JC. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002;59:862-867.
6. Tomsick T. TIMI, TIBI, TICI: I came, I saw, I got confused. AJNR Am J Neuroradiol. 2007;28:382-384.
7. De Silva DA, Fink JN, Christensen S, Ebinger M, Bladin C, Levi CR, et al; Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) Investigators. Assessing reperfusion and recanalization as markers of clinical outcomes after intravenous thrombolysis in the echoplanar imaging thrombolytic evaluation trial (EPITHET). Stroke. 2009;40:2872-2874. doi: 10.1161/STROKEAHA.108.543595.
8. Soares BP, Tong E, Hom J, Cheng SC, Bredno J, Boussel L, et al. Reperfusion is a more accurate predictor of follow-up infarct volume than recanalization: a proof of concept using CT in acute ischemic stroke patients. Stroke. 2010;41:e34-e40. doi: 10.1161/STROKEAHA.109.568766.
9. Eilaghi A, Brooks J, d'Esterre C, Zhang L, Swartz RH, Lee TY, et al. Reperfusion is a stronger predictor of good clinical outcome than recanalization in ischemic stroke. Radiology. 2013;269:240-248. doi: 10.1148/radiol.13122327.
10. Infeld B, Davis SM, Donnan GA, Lichtenstein M, Baird AE, Binns D, et al. Streptokinase increases luxury perfusion after stroke. Stroke. 1996;27:1524-1529.
11. Molina CA. Futile recanalization in mechanical embolectomy trials: a call to improve selection of patients for revascularization. Stroke. 2010;41:842-843. doi: 10.1161/STROKEAHA.110.580266.
12. Alawneh JA, Jones PS, Mikkelsen IK, Cho TH, Siemonsen S, Mouridsen K et al. Infarction of 'non-core-non-penumbral' tissue after stroke: multivariate modelling of clinical impact. Brain. 2011;134:1765-1776. doi:10.1093/brain/awr100.
13. Carrera E, Jones PS, Alawneh JA, Klærke Mikkelsen I, Cho TH, Siemonsen S, et al. Predicting infarction within the diffusion-weighted imaging lesion: does the mean transit time have added value Stroke. 2011;42:1602-1607. doi: 10.1161/STROKEAHA.110.606970.
14. Hermitte L, Cho TH, Ozenne B, Nighoghossian N, Mikkelsen IK, Ribe L, et al. Very low cerebral blood volume predicts parenchymal hematoma in acute ischemic stroke. Stroke. 2013;44:2318-2320. doi: 10.1161/STROKEAHA.113.001751.
15. Cheng B, Forkert ND, Zavaglia M, Hilgetag CC, Golsari A, Siemonsen S, et al. Influence of stroke infarct location on functional outcome measured by the modified rankin scale. Stroke. 2014;45:1695-1702. doi:10.1161/STROKEAHA.114.005152.
16. Albers GW, Thijs VN, Wechsler L, Kemp S, Schlaug G, Skalabrin E, et al; DEFUSE Investigators. Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study. Ann Neurol. 2006;60:508-517. doi: 10.1002/ana.20976.
17. Lansberg MG, Straka M, Kemp S, Mlynash M, Wechsler LR, Jovin TG, et al; DEFUSE 2 study investigators. MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study. Lancet Neurol. 2012;11:860-867. doi: 10.1016/S1474-4422(12)70203-X.
18. Khatri P, Neff J, Broderick JP, Khoury JC, Carrozzella J, Tomsick T; IMS-I Investigators. Revascularization end points in stroke interventional trials: recanalization versus reperfusion in IMS-I. Stroke. 2005;36:2400-2403. doi: 10.1161/01.STR.0000185698.45720.58.
19. Bang OY, Saver JL, Alger JR, Starkman S, Ovbiagele B, Liebeskind DS; UCLA Collateral Investigators. Determinants of the distribution and severity of hypoperfusion in patients with ischemic stroke. Neurology. 2008;71:1804-1811. doi: 10.1212/01.wnl.0000335929.06390.d3.
20. Campbell BC, Christensen S, Tress BM, Churilov L, Desmond PM, Parsons MW, et al; EPITHET Investigators. Failure of collateral blood flow is associated with infarct growth in ischemic stroke. J Cereb Blood Flow Metab. 2013;33:1168-1172. doi: 10.1038/jcbfm.2013.77.
21. Olivot JM, Mlynash M, Inoue M, Marks MP, Wheeler HM, Kemp S, et al; DEFUSE 2 Investigators. Hypoperfusion intensity ratio predicts infarct progression and functional outcome in the DEFUSE 2 Cohort. Stroke. 2014;45:1018-1023. doi: 10.1161/STROKEAHA.113.003857.
22. Marks MP, Lansberg MG, Mlynash M, Kemp S, McTaggart R, Zaharchuk G, et al; DEFUSE 2 Investigators. Correlation of AOL recanalization, TIMI reperfusion and TICI reperfusion with infarct growth and clinical outcome. J Neurointerv Surg. 2014;6:724-728. doi: 10.1136/neurintsurg-2013-010973.
23. Luby M, Warach SJ, Nadareishvili Z, Merino JG. Immediate changes in stroke lesion volumes post thrombolysis predict clinical outcome. Stroke. 2014;45:3275-3279. doi: 10.1161/STROKEAHA.114.006082.
24. Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P, Parsons MW. The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain. 2009;132:2231-2238. doi: 10.1093/brain/awp155.
25. Bang OY, Saver JL, Kim SJ, Kim GM, Chung CS, Ovbiagele B, et al. Collateral flow predicts response to endovascular therapy for acute ischemic stroke. Stroke. 2011;42:693-699. doi: 10.1161/STROKEAHA.110.595256.
26. Jung S, Gilgen M, Slotboom J, El-Koussy M, Zubler C, Kiefer C et al. Factors that determine penumbral tissue loss in acute ischaemic stroke. Brain. 2013;136:3554-3560. doi: 10.1093/brain/awt246.
27. Liebeskind DS, Tomsick TA, Foster LD, Yeatts SD, Carrozzella J, Demchuk AM, et al; IMS III Investigators. Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014;45:759-764. doi: 10.1161/STROKEAHA.113.004072.
28. Kim SJ, Son JP, Ryoo S, Lee MJ, Cha J, Kim KH, et al. A novel magnetic resonance imaging approach to collateral flow imaging in ischemic stroke. Ann Neurol. 2014;76:356-369. doi: 10.1002/ana.24211.
29. Bruno A, Levine SR, Frankel MR, Brott TG, Lin Y, Tilley BC, et al; NINDS rt-PA Stroke Study Group. Admission glucose level and clinical outcomes in the NINDS rt-PA Stroke Trial. Neurology. 2002;59:669-674.
30. Fuentes B, Castillo J, San José B, Leira R, Serena J, Vivancos J, et al; Stroke Project of the Cerebrovascular Diseases Study Group, Spanish Society of Neurology. The prognostic value of capillary glucose levels in acute stroke: the GLycemia in Acute Stroke (GLIAS) study. Stroke. 2009;40:562-568. doi: 10.1161/STROKEAHA.108.519926.
31. Labeyrie MA, Turc G, Hess A, Hervo P, Mas JL, Meder JF, et al. Diffusion lesion reversal after thrombolysis: a MR correlate of early neurological improvement. Stroke. 2012;43:2986-2991. doi: 10.1161/STROKEAHA.112.661009.
32. Khatri P, Abruzzo T, Yeatts SD, Nichols C, Broderick JP, Tomsick TA; IMS I and II Investigators. Good clinical outcome after ischemic stroke with successful revascularization is time-dependent. Neurology. 2009;73:1066-1072. doi: 10.1212/WNL.0b013e3181b9c847.
33. Takasawa M, Jones PS, Guadagno JV, Christensen S, Fryer TD, Harding S, et al. How reliable is perfusion MR in acute stroke Validation and determination of the penumbra threshold against quantitative PET. Stroke. 2008;39:870-877. doi: 10.1161/STROKEAHA.107.500090.
34. Zaro-Weber O, Moeller-Hartmann W, Heiss WD, Sobesky J. Maps of time to maximum and time to peak for mismatch definition in clinical stroke studies validated with positron emission tomography. Stroke. 2010;41:2817-2821. doi: 10.1161/STROKEAHA.110.594432.
35. Baron JC. Mapping the ischaemic penumbra with PET: implications for acute stroke treatment. Cerebrovasc Dis. 1999;9:193-201.